共 117 条
[101]
Francavilla, Cadrobbi, Scaggiante, Et al., Surveillance on occupational exposure to HIV among health-care workers in Italy, V International Conference on AIDS, (1989)
[102]
Henderson, HIV-1 in the health-care setting, Principles and Practice of Infectious Disease, (1990)
[103]
Kelen, Fritz, Qagish, Et al., Unrecognized human immunodeficiency vines infection in emergency department patients, N Engl J Med, 318, pp. 1645-1650, (1988)
[104]
Mitsuya, Weinhold, Furman, Et al., 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus in vitro, Proc Natl Acad Sci (USA), 82, pp. 7096-7100, (1985)
[105]
Fischl, Richman, Grieco, Et al., The efficacy of azidovudine in the treatment of patients with AIDS and AIDS-related complex: A double blind, placebo-controlled trial, N Engl J Med, 317, pp. 185-191, (1987)
[106]
Richman, Fischl, Grieco, Et al., The toxicity of azidovudine in the treatment of patients with AIDS and AIDS-related complex: A double blind, placebo-controlled trial, N Engl J Med, 317, pp. 192-197, (1987)
[107]
Yarchoan, Klecker, Weinhold, Et al., Administration of 3′-Azido-3′-deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS-related complex, Lancet, 1, pp. 575-580, (1986)
[108]
Centers for Disease Control, Management of occupational exposure to HIV: Including considerations regarding post-exposure use of zidovudine, MMWR, 39, pp. 1-14, (1990)
[109]
Sacks, Rose, Zidovudine prophylaxis for needlestick exposure to human immunodeficiency virus: A decision analysis, J Gen Intern Med, 5, pp. 132-137, (1990)
[110]
Ruprecht, O'Brien, Rossoni, Et al., Suppression of mouse viremia and retroviral disease by 3′-Azido-3′-deoxythymidine, Nature, 323, pp. 467-469, (1986)